PL377504A1 - Pochodne (2-aminofenylo)amidu kwasu arylenokarboksylowego jako środki framaceutyczne - Google Patents

Pochodne (2-aminofenylo)amidu kwasu arylenokarboksylowego jako środki framaceutyczne

Info

Publication number
PL377504A1
PL377504A1 PL377504A PL37750403A PL377504A1 PL 377504 A1 PL377504 A1 PL 377504A1 PL 377504 A PL377504 A PL 377504A PL 37750403 A PL37750403 A PL 37750403A PL 377504 A1 PL377504 A1 PL 377504A1
Authority
PL
Poland
Prior art keywords
arylene
phenyl
amino
carboxylic acid
pharmaceutical agents
Prior art date
Application number
PL377504A
Other languages
English (en)
Inventor
Georg Fertig
Frank Herting
Matthias Koerner
Manfred Kubbies
Anja Limberg
Ulrike Reiff
Michael Weidner
Original Assignee
F. Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche Ag filed Critical F. Hoffmann-La Roche Ag
Publication of PL377504A1 publication Critical patent/PL377504A1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D333/40Thiophene-2-carboxylic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/64Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/77Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/42Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/20Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C275/24Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/10Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL377504A 2002-12-10 2003-12-09 Pochodne (2-aminofenylo)amidu kwasu arylenokarboksylowego jako środki framaceutyczne PL377504A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02027579 2002-12-10

Publications (1)

Publication Number Publication Date
PL377504A1 true PL377504A1 (pl) 2006-02-06

Family

ID=32479720

Family Applications (1)

Application Number Title Priority Date Filing Date
PL377504A PL377504A1 (pl) 2002-12-10 2003-12-09 Pochodne (2-aminofenylo)amidu kwasu arylenokarboksylowego jako środki framaceutyczne

Country Status (18)

Country Link
US (1) US7098247B2 (pl)
EP (1) EP1572625A1 (pl)
JP (1) JP2006509021A (pl)
KR (1) KR100759744B1 (pl)
CN (2) CN1723192A (pl)
AR (1) AR042341A1 (pl)
AU (1) AU2003289992A1 (pl)
BR (1) BR0317027A (pl)
CA (1) CA2507137A1 (pl)
GT (1) GT200300274A (pl)
MX (1) MXPA05005977A (pl)
PA (1) PA8590901A1 (pl)
PE (1) PE20040768A1 (pl)
PL (1) PL377504A1 (pl)
RU (1) RU2345061C2 (pl)
TW (1) TW200426138A (pl)
UY (1) UY28108A1 (pl)
WO (1) WO2004052838A1 (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7154002B1 (en) 2002-10-08 2006-12-26 Takeda San Diego, Inc. Histone deacetylase inhibitors
US7250514B1 (en) 2002-10-21 2007-07-31 Takeda San Diego, Inc. Histone deacetylase inhibitors
KR20050122210A (ko) 2003-03-17 2005-12-28 다케다 샌디에고, 인코포레이티드 히스톤 탈아세틸화 효소 억제제
US9115090B2 (en) 2003-12-02 2015-08-25 The Ohio State University Research Foundation Zn2+-chelating motif-tethered short-chain fatty acids as a novel class of histone deacetylase inhibitors
JP2008524246A (ja) * 2004-12-16 2008-07-10 タケダ サン ディエゴ インコーポレイテッド ヒストンデアセチラーゼ阻害剤
WO2006122319A2 (en) 2005-05-11 2006-11-16 Takeda San Diego, Inc. Histone deacetylase inhibitors
ZA200800901B (en) 2005-07-14 2010-05-26 Takeda San Diego Inc Histone deacetylase inhibitors
CA2642813A1 (en) * 2006-02-28 2007-09-07 Merck & Co., Inc. Inhibitors of histone deacetylase
KR20090125209A (ko) 2007-03-28 2009-12-03 산텐 세이야꾸 가부시키가이샤 히스톤 탈아세틸화 효소 저해 작용을 갖는 화합물을 유효 성분으로서 함유하는 안압 하강제
JP5150332B2 (ja) * 2007-03-28 2013-02-20 参天製薬株式会社 ウレア構造を有する新規ピリジンカルボン酸(2−アミノフェニル)アミド誘導体
AU2008309269B2 (en) * 2007-10-10 2012-06-07 Orchid Research Laboratories Limited Novel histone deacetylase inhibitors
WO2009142321A1 (ja) 2008-05-23 2009-11-26 参天製薬株式会社 ウレア構造を有する新規チオフェンジアミン誘導体
AU2009289649B2 (en) 2008-09-03 2016-05-05 Biomarin Pharmaceutical Inc. Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors
ES2463826T3 (es) * 2009-06-08 2014-05-29 Gilead Sciences, Inc. Compuestos inhibidores de HDAC de cicloalquilcarbamato benzamida anilina
US8957066B2 (en) 2011-02-28 2015-02-17 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
JP6250403B2 (ja) 2011-02-28 2017-12-20 バイオマリン ファーマシューティカル インク ヒストン脱アセチル化酵素阻害剤
US10059723B2 (en) 2011-02-28 2018-08-28 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
PT2970139T (pt) 2013-03-15 2018-08-01 Biomarin Pharm Inc Inibidores de hdac
PL237497B1 (pl) * 2018-09-17 2021-04-19 Univ Medyczny Im Piastow Slaskich We Wroclawiu Hydrazyd kwasu N’-[(antracen-9-ylo)metyleno]-2-[4,6-dimetylo- 2-sulfanylopirydyn-3-ylo-karboksamido]octowego, sposób jego otrzymywania i zastosowanie

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1033046B (it) 1970-10-31 1979-07-10 Finotto Martino Procedimento di fabbricazione di benzimidazoli sostituiti
DE2201062A1 (de) 1972-01-11 1973-07-26 Bayer Ag N-alkoxycarbonyl- bzw. n-alkylthiocarbonyl-2-(2'-thienyl)-benzimidazole, ein verfahren zu ihrer herstellung und ihre verwendung als fungizide
NZ219974A (en) * 1986-04-22 1989-08-29 Goedecke Ag N-(2'-aminophenyl)-benzamide derivatives, process for their preparation and their use in the control of neoplastic diseases
JPH0242851A (ja) * 1988-08-02 1990-02-13 Nec Corp 回線選択装置
DE59410119D1 (de) * 1993-07-02 2002-06-20 Byk Gulden Lomberg Chem Fab Fluoralkoxy substituierte benzamide und ihre verwendung als zyklisch-nukleotid phosphodiesterase-inhibitoren
JPH0847992A (ja) * 1994-08-05 1996-02-20 Nippon Petrochem Co Ltd 高弾性率網状ウェブによる立体複合補強体およびその製法
US6174905B1 (en) * 1996-09-30 2001-01-16 Mitsui Chemicals, Inc. Cell differentiation inducer

Also Published As

Publication number Publication date
AU2003289992A1 (en) 2004-06-30
PE20040768A1 (es) 2004-11-20
CA2507137A1 (en) 2004-06-24
WO2004052838A1 (en) 2004-06-24
EP1572625A1 (en) 2005-09-14
BR0317027A (pt) 2005-10-25
US20040138270A1 (en) 2004-07-15
US7098247B2 (en) 2006-08-29
PA8590901A1 (es) 2004-11-26
MXPA05005977A (es) 2005-08-18
AR042341A1 (es) 2005-06-15
KR100759744B1 (ko) 2007-10-04
TW200426138A (en) 2004-12-01
CN1723192A (zh) 2006-01-18
JP2006509021A (ja) 2006-03-16
RU2005121662A (ru) 2006-01-27
GT200300274A (es) 2004-09-02
UY28108A1 (es) 2004-06-30
RU2345061C2 (ru) 2009-01-27
CN101279927A (zh) 2008-10-08
KR20050088421A (ko) 2005-09-06

Similar Documents

Publication Publication Date Title
ZA200604352B (en) Azepinondole derivatives as pharmaceutical agents
GB2389530B (en) Pharmaceutical compositions
EG25614A (en) Novel pyrroles derivatives as pharmaceutical agents
AU2003291103A8 (en) Pharmaceutical composition
GB0012850D0 (en) Cyclic amino acid derivatives useful as pharmaceutical agents
IL164547A0 (en) Pharmaceutical composition
PT1467724E (pt) Composicao farmaceutica orodispersavel de agomelatina
GB2391473B (en) Pharmaceutical compositions
AU2003250372A8 (en) Pharmaceutical composition
PL371344A1 (pl) Benzenoamidowe pochodne jako środki antypsychotyczne
IL170316A (en) Cycloalkyl-methoxy substituted acetic acid derivatives and pharmaceutical compositions comprising them
PL373624A1 (pl) Pochodne kwasu 4-(7-fluorowco-2-chino(ksa)linylooksy)-fenoksy propionowego jako środki przeciwnowotworowe
GB0129988D0 (en) Imidazolidineacetic acid derivatives
GB0213481D0 (en) Pharmaceutical compositions
IL174248A0 (en) Alkyl carboxylic acid derivatives and pharmaceutical compositions containing the same
SI1590314T1 (sl) 2-aril-ocetne kisline, njihovi derivati in farmacevtski sestavki, ki jih vsebujejo
EP1389119A4 (en) PHARMACEUTICAL COMPOSITION BASED ON LYSOPHOSPHATIDE ACID
AU2003291642A8 (en) Pyrazoloazepine compounds as pharmaceutical agents
EP1480649A4 (en) STABLE PHARMACEUTICAL COMPOSITIONS
PL370907A1 (pl) Kompozycje farmaceutyczne
GB0217703D0 (en) Pharmaceutical composition
GB0225880D0 (en) Pharmaceutical compositions
GB0209379D0 (en) Pharmaceutical compositions
GB0221068D0 (en) Pharmaceutical compositions
GB0210663D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)